Journal article
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada
Abstract
BACKGROUND: Hepatocellular carcinoma (HCC) a leading cause of cancer mortality worldwide and approximately one-third of patients present with intermediate-stage disease. The treatment landscape of intermediate-stage HCC is rapidly evolving due to developments in local, locoregional and systemic therapies. Treatment recommendations focused on this heterogenous disease stage and that take into account the Canadian reality are lacking. To address …
Authors
Wong JK; Lim HJ; Tam VC; Burak KW; Dawson LA; Chaudhury P; Abraham RJ; Meyers BM; Sapisochin G; Valenti D
Journal
Cancer Treatment Reviews, Vol. 115, ,
Publisher
Elsevier
Publication Date
4 2023
DOI
10.1016/j.ctrv.2023.102526
ISSN
0305-7372